Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,248 public trials 1,189 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer

NCT01109524

Conditions
Bronchial Neoplasms, Cancer of the Lung, Carcinoma, +12 more
Locations
  • Donald W. Hill M.D., P.C. Casa Grande, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Cancer Care Institute Los Angeles, California, United States
  • Northern California Hematology & Oncology Oakland, California, United States
View all 22 locations
View Trial Details
Completed

Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

NCT00112294

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Local Institution Birmingham, Alabama, United States
  • Local Institution Mobile, Alabama, United States
  • Local Institution Anchorage, Alaska, United States
  • Local Institution Tucson, Arizona, United States
View all 124 locations
View Trial Details
Completed

Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung Cancer

NCT00510445

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
  • The University of Texas Southwestern Medical Center Dallas, Texas, United States
  • UT MD Anderson Cancer Center Houston, Texas, United States
  • University of Wisconsin, Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States
View Trial Details
Completed

A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer

NCT00762034

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fayetteville, Arkansas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jonesboro, Arkansas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alhambra, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bakersfield, California, United States
View all 67 locations
View Trial Details
Completed

Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer

NCT01263886

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Investigational Site Number 840001 Muscle Shoals, Alabama, United States
  • Investigational Site Number 840003 Hot Springs, Arkansas, United States
  • Investigational Site Number 840002 Anaheim, California, United States
  • Investigational Site Number 840009 Modesto, California, United States
View all 43 locations
View Trial Details
Completed

A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) (Stage IIIB/IV Non-small Cell Lung Cancer).

NCT01153399

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Athens, Greece
  • Research Site Crete, Greece
  • Research Site Ioannina, Greece
  • Research Site Kavala, Greece
View Trial Details

Related conditions